awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33917530-896FE6E1-27A1-4F2D-AFD6-6271BAE99584
Q33917530-896FE6E1-27A1-4F2D-AFD6-6271BAE99584
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33917530-896FE6E1-27A1-4F2D-AFD6-6271BAE99584
Dual Aurora A and JAK2 kinase blockade effectively suppresses malignant transformation.
P2860
Q33917530-896FE6E1-27A1-4F2D-AFD6-6271BAE99584
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33917530-896FE6E1-27A1-4F2D-AFD6-6271BAE99584
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
4ff69ccd749287131e795e000ada2627d2e40070
P2860
Phase 2 study of the JAK kinase inhibitor ruxolitinib in patients with refractory leukemias, including postmyeloproliferative neoplasm acute myeloid leukemia.